{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:08:35Z","timestamp":1768295315893,"version":"3.49.0"},"reference-count":98,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T00:00:00Z","timestamp":1589587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>The paradigm of how we manage allergic rhinitis is shifting with a growing understanding that it is a complex process, requiring a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, improving adherence and recommending therapies while establishing liaisons between patients and physicians. Community pharmacists are the most accessible healthcare professionals to the public and allergic rhinitis is one of the most common diseases managed by pharmacists. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines developed over the past 20 years have improved the care of allergic rhinitis patients through an evidence-based, integrated care approach. In this paper, we propose an integrated approach to allergic rhinitis management in community pharmacy following the 2019 ARIA in the pharmacy guidelines.<\/jats:p>","DOI":"10.3390\/pharmacy8020085","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T02:43:42Z","timestamp":1589769822000},"page":"85","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8401-5976","authenticated-orcid":false,"given":"Olga","family":"Louren\u00e7o","sequence":"first","affiliation":[{"name":"Faculty of Health Sciences and CICS\u2014UBI, Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilh\u00e3, Portugal"}]},{"given":"Sinthia","family":"Bosnic-Anticevich","sequence":"additional","affiliation":[{"name":"Woolcock Institute of Medical Research, Faculty of Medicine and Health, University of Sydney, Sydney 2037, Australia"}]},{"given":"El\u00edsio","family":"Costa","sequence":"additional","affiliation":[{"name":"UCIBIO, REQUIMTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing (AgeUPNetWork), University of Porto, 4150 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0887-8796","authenticated-orcid":false,"given":"Jo\u00e3o A.","family":"Fonseca","sequence":"additional","affiliation":[{"name":"CINTESIS\u2014Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal"}]},{"given":"Enrica","family":"Menditto","sequence":"additional","affiliation":[{"name":"CIRFF, Center of Pharmacoeconomics, University of Naples Federico II, 80138 Naples, Italy"}]},{"given":"Biljana","family":"Cvetkovski","sequence":"additional","affiliation":[{"name":"Woolcock Institute of Medical Research, Faculty of Medicine and Health, University of Sydney, Sydney 2037, Australia"}]},{"given":"Vicky","family":"Kritikos","sequence":"additional","affiliation":[{"name":"Woolcock Institute of Medical Research, Faculty of Medicine and Health, University of Sydney, Sydney 2037, Australia"}]},{"given":"Rachel","family":"Tan","sequence":"additional","affiliation":[{"name":"Woolcock Institute of Medical Research, Faculty of Medicine and Health, University of Sydney, Sydney 2037, Australia"}]},{"given":"Anna","family":"Bedbrook","sequence":"additional","affiliation":[{"name":"MACVIA-France, 34295 Montpellier, France"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9623-4458","authenticated-orcid":false,"given":"Sophie","family":"Scheire","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[{"name":"Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital, 9000 Ghent, Belgium"},{"name":"International Airway Research Center, First Affiliated Hospital Guangzhou, Sun Yat-sen University, Guangzhou 510275, China"},{"name":"Department of Medicine Solna, Immunology and Allergy Research Unit, Karolinska Institute, 171 77 Stockholm, Sweden"}]},{"given":"S\u0142awomir","family":"Bia\u0142ek","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Clinical Chemistry, Faculty of Pharmacy with the Division of Laboratory Medicine, Warsaw Medical University, 02-091 Warsaw, Poland"}]},{"given":"Vitalis","family":"Briedis","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}]},{"given":"Koen","family":"Boussery","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium"}]},{"given":"G. Walter","family":"Canonica","sequence":"additional","affiliation":[{"name":"Personalized Medicine Clinic Asthma &amp; Allergy, Humanitas University, Humanitas Research Hospital, 20089 Rozzano MI, Italy"}]},{"given":"Tari","family":"Haahtela","sequence":"additional","affiliation":[{"name":"Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, 00100 Helsinki, Finland"}]},{"given":"Piotr","family":"Kuna","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of \u0141\u00f3d\u017a, 90-419 \u0141\u00f3d\u017a, Poland"}]},{"given":"Ettore","family":"Novellino","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Naples Federico II, 80138 Naples, Italy"}]},{"given":"Boles\u0142aw","family":"Samoli\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Prevention of Environmental Hazards and Allergology, Warsaw Medical University, 02-091 Warsaw, Poland"}]},{"given":"Holger J.","family":"Sch\u00fcnemann","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, Division of Immunology and Allergy, McMaster University, Hamilton, ON L8S 4L8, Canada"}]},{"given":"Dana","family":"Wallace","sequence":"additional","affiliation":[{"name":"College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33314, USA"}]},{"given":"Jean","family":"Bousquet","sequence":"additional","affiliation":[{"name":"MACVIA-France, 34295 Montpellier, France"},{"name":"Centre Hospitalier Universitaire de Montpellier, 34295 Montpellier, France"},{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Comprehensive Allergy Center, Department of Dermatology and Allergy, Berlin Institute of Health, 10178 Berlin, Germany"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1002\/alr.21385","article-title":"Epidemiology of allergic rhinitis","volume":"4","author":"Mims","year":"2014","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.2500\/aap.2012.33.3603","article-title":"Burden of allergic rhinitis: Allergies in America, Latin America, and Asia-Pacific adult surveys","volume":"33","author":"Meltzer","year":"2012","journal-title":"Allergy Asthma Proc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.iac.2015.12.010","article-title":"Rhinitis in the elderly","volume":"36","author":"Baptist","year":"2016","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hill, D.A., Grundmeier, R.W., Ram, G., and Spergel, J.M. (2016). The epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy in children: A retrospective cohort study. BMC Pediatr., 16.","DOI":"10.1186\/s12887-016-0673-z"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jaci.2017.03.050","article-title":"Allergic rhinitis and its impact on asthma (ARIA) guidelines\u20142016 revision","volume":"140","author":"Brozek","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jaip.2017.09.002","article-title":"Impact of rhinitis on work productivity: A systematic review","volume":"6","author":"Vandenplas","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13601-018-0212-0","article-title":"Severity of allergic rhinitis impacts sleep and anxiety: Results from a large Spanish cohort","volume":"8","author":"Ribo","year":"2018","journal-title":"Clin. Transl. Allergy"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2500\/ajra.2017.31.4444","article-title":"Association between symptoms of allergic rhinitis with decreased general health-related quality of life","volume":"31","author":"Hoehle","year":"2017","journal-title":"Am. J. Rhinol. Allergy"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.iac.2015.12.002","article-title":"Allergic rhinitis: Burden of illness, quality of life, comorbidities, and control","volume":"36","author":"Meltzer","year":"2016","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13601-018-0210-2","article-title":"Rapid onset of action and reduced nasal hyperreactivity: New targets in allergic rhinitis management","volume":"8","author":"Bachert","year":"2018","journal-title":"Clin. Transl. Allergy"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41533-018-0071-0","article-title":"Tell me about your hay fever: A qualitative investigation of allergic rhinitis management from the perspective of the patient","volume":"28","author":"Cvetkovski","year":"2018","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1742-1241.2008.01944.x","article-title":"Is reliance on self-medication and pharmacy care adequate for rhinitis patients?","volume":"63","author":"Williams","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2050312115595822","DOI":"10.1177\/2050312115595822","article-title":"Understanding the role of the healthcare professional in patient self-management of allergic rhinitis","volume":"3","author":"Kuehl","year":"2015","journal-title":"SAGE Open Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/02770903.2017.1353611","article-title":"Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed-dose combination therapy in Australia","volume":"55","author":"Kritikos","year":"2018","journal-title":"J. Asthma"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2147\/PPA.S164819","article-title":"Adherence to chronic medication in older populations: Application of a common protocol among three European cohorts","volume":"12","author":"Menditto","year":"2018","journal-title":"Patient Prefer. Adherence"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/cea.13333","article-title":"Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study","volume":"49","author":"Menditto","year":"2019","journal-title":"Clin. Exp. Allergy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/all.13448","article-title":"Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study","volume":"73","author":"Bousquet","year":"2018","journal-title":"Allergy"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma","volume":"108","author":"Bousquet","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2010.06.047","article-title":"Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision","volume":"126","author":"Brozek","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Members of the Workshops (2004). ARIA in the pharmacy: Management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma. Allergy, 59, 373\u2013387.","DOI":"10.1111\/j.1398-9995.2003.00468.x"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.13701","article-title":"ARIA pharmacy 2018 \u201cAllergic rhinitis care pathways for community pharmacy\u201d: AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Sante) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project","volume":"74","author":"Costa","year":"2019","journal-title":"Allergy"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13601-016-0137-4","article-title":"ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle","volume":"6","author":"Bousquet","year":"2016","journal-title":"Clin. Transl. Allergy"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13601-018-0227-6","article-title":"MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence","volume":"8","author":"Bousquet","year":"2018","journal-title":"Clin. Transl. Allergy"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13601-019-0252-0","article-title":"Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma","volume":"9","author":"Bousquet","year":"2019","journal-title":"Clin. Transl. Allergy"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"European Innovation Partnership on Active and Healthy Ageing Action Plan B3, Mechanisms of the Development of Allergy WP10, Global Alliance against Chronic Respiratory Diseases, Bousquet, J., Addis, A., Adcock, I., Agache, I., Agusti, A., Alonso, A., and Annesi-Maesano, I. (2014). Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur. Respir. J., 44, 304\u2013323.","DOI":"10.1183\/09031936.00014614"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1183\/13993003.01856-2015","article-title":"AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation","volume":"47","author":"Bousquet","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13601-019-0279-2","article-title":"Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases","volume":"9","author":"Bousquet","year":"2019","journal-title":"Clin. Transl. Allergy"},{"key":"ref_29","unstructured":"Bousquet, J., Schunemann, H.J., Togias, A., Bachert, C., Erhola, M., Hellings, P.W., Klimek, L., Pfaar, O., Wallace, D., and Ansotegui, I. (2019). Next-generation allergic rhinitis and its impact on asthma (ARIA) guidelines for allergic rhinitis based on grading of recommendations assessment, development and evaluation (GRADE) and real-world evidence. J. Allergy Clin. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13601-016-0116-9","article-title":"Scaling up strategies of the chronic respiratory disease programme of the European innovation partnership on active and healthy ageing (Action Plan B3: Area 5)","volume":"6","author":"Bousquet","year":"2016","journal-title":"Clin. Transl. Allergy"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/all.13218","article-title":"Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA)\u2014EIP on AHA twinning reference site (GARD research demonstration project)","volume":"73","author":"Bousquet","year":"2018","journal-title":"Allergy"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13601-019-0242-2","article-title":"Vilnius declaration on chronic respiratory diseases: Multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases","volume":"9","author":"Valiulis","year":"2019","journal-title":"Clin. Transl. Allergy"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jaci.2018.08.049","article-title":"Allergic rhinitis and its impact on asthma (ARIA) phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology","volume":"143","author":"Bousquet","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ACI.0000000000000375","article-title":"Seasonal allergic rhinitis: A focused systematic review and practice parameter update","volume":"17","author":"Wallace","year":"2017","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jaip.2018.01.028","article-title":"The burden of rhinitis and the impact of medication management within the community pharmacy setting","volume":"6","author":"Tan","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaci.2010.06.034","article-title":"Uncontrolled allergic rhinitis during treatment and its impact on quality of life: A cluster randomized trial","volume":"126","author":"Bousquet","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40733-017-0036-z","article-title":"Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: A global phenomenon","volume":"3","author":"Tan","year":"2017","journal-title":"Asthma Res. Pract."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino12.000","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(08)61446-4","article-title":"Rhinitis and onset of asthma: A longitudinal population-based study","volume":"372","author":"Shaaban","year":"2008","journal-title":"Lancet"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1398-9995.2008.01715.x","article-title":"Important research questions in allergy and related diseases: Nonallergic rhinitis: A GA2LEN paper","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ACI.0000000000000204","article-title":"Epidemiology of allergic conjunctivitis: Clinical appearance and treatment patterns in a population-based study","volume":"15","author":"Leonardi","year":"2015","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_42","first-page":"233","article-title":"Coexistence of asthma and allergic rhinitis in adult patients attending allergy clinics: ONEAIR study","volume":"18","author":"Navarro","year":"2008","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.2500\/ajra.2011.25.3607","article-title":"Impact of allergic rhinitis on bronchi: An 8-year follow-up study","volume":"25","author":"Ciprandi","year":"2011","journal-title":"Am. J. Rhinol. Allergy"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4104\/pcrj.2009.00037","article-title":"The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control","volume":"18","author":"Clatworthy","year":"2009","journal-title":"Prim. Care Respir. J."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Bousquet, J., Pfaar, O., Togias, A., Schunemann, H.J., Ansotegui, I., Papadopoulos, N.G., Tsiligianni, I., Agache, I., Anto, J.M., and Bachert, C. (2019). 2019 ARIA Care pathways for allergen immunotherapy. Allergy.","DOI":"10.26416\/Aler.3.4.2019.2749"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/ajhp\/61.15.1599","article-title":"Computer-based system for preventing adverse drug events","volume":"61","author":"Silverman","year":"2004","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5455\/medarh.2013.67.126-130","article-title":"Evaluate the ability of clinical decision support systems (CDSSs) to improve clinical practice","volume":"67","author":"Ajami","year":"2013","journal-title":"Med. Arch."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2146\/ajhp080122","article-title":"Evaluation of a computer-based adverse-drug-event monitor","volume":"65","author":"Hwang","year":"2008","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1111\/jgs.16078","article-title":"Impact of computer-based and pharmacist-assisted medication review initiated in the emergency department","volume":"67","author":"Liu","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11096-011-9584-0","article-title":"Assessment of a computerised decision support system for allergic rhino-conjunctivitis counselling in German pharmacy","volume":"34","author":"Bertsche","year":"2012","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/cea.13230","article-title":"Electronic clinical decision support system for allergic rhinitis management: MASK e-CDSS","volume":"48","author":"Courbis","year":"2018","journal-title":"Clin. Exp. Allergy"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/cea.12121","article-title":"Visual analogue scale in patients treated for allergic rhinitis: An observational prospective study in primary care: Asthma and rhinitis","volume":"43","author":"Demoly","year":"2013","journal-title":"Clin. Exp. Allergy"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000342991","article-title":"Impact of allergic rhinitis symptoms on quality of life in primary care","volume":"160","author":"Bousquet","year":"2013","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4104\/pcrj.2013.00012","article-title":"Control of allergic rhinitis and asthma test (CARAT): Dissemination and applications in primary care","volume":"22","author":"Azevedo","year":"2013","journal-title":"Prim. Care Respir. J."},{"key":"ref_55","first-page":"513","article-title":"Evaluation of allergic rhinitis and asthma control in a Portuguese community pharmacy setting","volume":"20","author":"Lourenco","year":"2014","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_56","first-page":"108","article-title":"International consensus statement on allergy and rhinology: Allergic rhinitis","volume":"8","author":"Wise","year":"2018","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_57","first-page":"S1","article-title":"Clinical practice guideline: Allergic rhinitis","volume":"152","author":"Seidman","year":"2015","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4104\/pcrj.2010.00044","article-title":"Management of allergic and non-allergic rhinitis: A primary care summary of the BSACI guideline","volume":"19","author":"Angier","year":"2010","journal-title":"Prim. Care Respir. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/all.12235","article-title":"Paediatric rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology","volume":"68","author":"Roberts","year":"2013","journal-title":"Allergy"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.anai.2009.11.020","article-title":"Evaluating approved medications to treat allergic rhinitis in the United States: An evidence-based review of efficacy for nasal symptoms by class","volume":"104","author":"Benninger","year":"2010","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.clinthera.2017.10.006","article-title":"Management of allergic rhinitis: A review for the community pharmacist","volume":"39","author":"May","year":"2017","journal-title":"Clin. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"l131","DOI":"10.1136\/bmj.l131","article-title":"Chronic rhinosinusitis","volume":"364","author":"Carter","year":"2019","journal-title":"BMJ"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2500\/aap.2014.35.3725","article-title":"Intranasal corticosteroids: The role of patient preference and satisfaction","volume":"35","author":"Sher","year":"2014","journal-title":"Allergy Asthma Proc."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2500\/ar.2016.7.0185","article-title":"A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis","volume":"7","author":"Yanez","year":"2016","journal-title":"Allergy Rhinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.pec.2018.05.018","article-title":"Evaluation of a structured pharmacist-led inhalation technique assessment service for patients with asthma and COPD in Norwegian pharmacies","volume":"101","author":"Ruud","year":"2018","journal-title":"Patient Educ. Couns."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.rmed.2016.10.006","article-title":"Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease","volume":"120","author":"Yesilyaprak","year":"2016","journal-title":"Respir. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/bcp.12242","article-title":"Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): A randomized controlled trial","volume":"77","author":"Tommelein","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1345\/aph.1E474","article-title":"When does pharmaceutical care impact health outcomes? A comparison of community pharmacy-based studies of pharmaceutical care for patients with asthma","volume":"39","author":"McLean","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1017\/S0022215117002080","article-title":"Does intranasal steroid spray technique affect side effects and compliance? Results of a patient survey","volume":"131","author":"Ganesh","year":"2017","journal-title":"J. Laryngol. Otol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2147\/OPTH.S13479","article-title":"Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis","volume":"4","author":"Williams","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"ref_71","first-page":"85","article-title":"Azelastine\/fluticasone propionate(Dymista) for seasonal allergic rhinitis","volume":"54","author":"Berger","year":"2012","journal-title":"Med. Lett. Drugs Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1517\/14656566.2015.1020789","article-title":"Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps","volume":"16","author":"Bousquet","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40733-015-0002-6","article-title":"The patient with rhinitis in the pharmacy. A cross-sectional study in real life","volume":"1","author":"Lombardi","year":"2015","journal-title":"Asthma Res. Pract."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1398-9995.2009.02325.x","article-title":"Risk of first-generation H(1)-antihistamines: A GA(2)LEN position paper","volume":"65","author":"Church","year":"2010","journal-title":"Allergy"},{"key":"ref_75","first-page":"k3786","article-title":"What treatments are effective for common cold in adults and children?","volume":"363","author":"Scheire","year":"2018","journal-title":"BMJ"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: An updated practice parameter","volume":"122","author":"Wallace","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00151829-200504010-00003","article-title":"Rhinitis medicamentosa: A review of causes and treatment","volume":"4","author":"Graf","year":"2005","journal-title":"Treat. Respir. Med."},{"key":"ref_78","first-page":"148","article-title":"Rhinitis medicamentosa","volume":"16","author":"Ramey","year":"2006","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jaip.2014.01.009","article-title":"Self-medication in persistent rhinitis: Overuse of decongestants in half of the patients","volume":"2","author":"Mehuys","year":"2014","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/IJGM.S8184","article-title":"Treatment of congestion in upper respiratory diseases","volume":"3","author":"Meltzer","year":"2010","journal-title":"Int. J. Gen. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jaip.2014.01.006","article-title":"Are you comfortable with over-the-counter intranasal steroids for children? A call to action","volume":"2","author":"Rachelefsky","year":"2014","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1398-9995.2000.00526.x","article-title":"Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology","volume":"55","author":"Bachert","year":"2000","journal-title":"Allergy"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"15082","DOI":"10.1038\/npjpcrm.2015.82","article-title":"TOTALL: High cost of allergic rhinitis-a national Swedish population-based questionnaire study","volume":"26","author":"Cardell","year":"2016","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1183\/20734735.015614","article-title":"Supported self-management for asthma","volume":"11","author":"Pinnock","year":"2015","journal-title":"Breathe"},{"key":"ref_85","first-page":"CD011682","article-title":"Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease","volume":"8","author":"Lenferink","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.2105\/AJPH.2014.302041","article-title":"Self-management: A comprehensive approach to management of chronic conditions","volume":"104","author":"Grady","year":"2014","journal-title":"Am. J. Public Health"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.colegn.2012.12.005","article-title":"Asthma self management in adults: A review of current literature","volume":"21","author":"Andrews","year":"2014","journal-title":"Collegian"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pec.2007.09.004","article-title":"Healthcare professional versus patient goal setting in intermittent allergic rhinitis","volume":"70","author":"Seeto","year":"2008","journal-title":"Patient Educ. Couns."},{"key":"ref_89","first-page":"CD011425","article-title":"Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease","volume":"5","author":"McCabe","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_90","first-page":"1124","article-title":"Asthma controller medication adherence, risk of exacerbation, and use of rescue agents among Texas medicaid patients with persistent asthma","volume":"21","author":"Makhinova","year":"2015","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1398-9995.2009.02161.x","article-title":"Persistence with asthma treatment is low in Germany especially for controller medication\u2014A population based study of 483,051 patients","volume":"65","author":"Hasford","year":"2010","journal-title":"Allergy"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2015.7667","article-title":"Mobile telephone text messaging for medication adherence in chronic disease: A meta-analysis","volume":"176","author":"Thakkar","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.2196\/mhealth.6742","article-title":"Mobile phone apps to improve medication adherence: A systematic stepwise process to identify high-quality apps","volume":"4","author":"Santo","year":"2016","journal-title":"JMIR mHealth uHealth"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/ijpp.12462","article-title":"Community pharmacist-led interventions and their impact on patients\u2019 medication adherence and other health outcomes: A systematic review","volume":"26","author":"Milosavljevic","year":"2018","journal-title":"Int. J. Pharm. Pract."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/all.13177","article-title":"Work productivity in rhinitis using cell phones: The MASK pilot study","volume":"72","author":"Bousquet","year":"2017","journal-title":"Allergy"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/all.13307","article-title":"The allergic rhinitis and its impact on asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study","volume":"73","author":"Bousquet","year":"2018","journal-title":"Allergy"},{"key":"ref_97","first-page":"36","article-title":"MASK-rhinitis, a single tool for integrated care pathways in allergic rhinitis","volume":"51","author":"Bourret","year":"2015","journal-title":"World Hosp. Health Serv."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1398-9995.2006.01276.x","article-title":"Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines","volume":"62","author":"Bousquet","year":"2007","journal-title":"Allergy"}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/8\/2\/85\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:29:26Z","timestamp":1760174966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/8\/2\/85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,16]]},"references-count":98,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["pharmacy8020085"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy8020085","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,16]]}}}